RBC maintains Sarepta Therapeutics at Sector Perform
RBC Capital maintained Sarepta Therapeutics at Sector Perform and cut its price target to $17.00 from $19.00.
Story updates
02:24:35 PM UTC
SquawkNews
Sarepta Therapeutics Is Maintained at Sector Perform by RBC Capital